Voltaren Emulgel pain relief gel

Voltaren Emulgel is a well-known topical pain relief medication containing diclofenac diethylamine. The brand has its roots in Switzerland, where it was developed by Ciba-Geigy, a predecessor company that eventually merged with Sandoz to form Novartis in 1996.

Today, the Voltaren brand is part of the consumer healthcare portfolio of Haleon plc. Haleon was formed as a result of a joint venture between GSK (GlaxoSmithKline) and Pfizer, subsequently spinning off as a standalone independent company in 2022. Because of its global reach, Voltaren is manufactured in multiple high-standard pharmaceutical facilities located in various countries, including Germany, Canada, and India, depending on the specific regional market and distribution requirements.